{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:13:52Z","timestamp":1745986432971,"version":"3.40.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Orthopedics and Sports Rehabilitation Clinical Medicine Research Center","award":["202102AA310068"],"award-info":[{"award-number":["202102AA310068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95467-z","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T09:53:38Z","timestamp":1745920418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the association between systemic lupus erythematosus and osteonecrosis by Mendelian randomization analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Baochuang","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu Qiao","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanqiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"5","key":"95467_CR1","first-page":"997","volume":"41","author":"D Zucchi","year":"2023","unstructured":"Zucchi, D. et al. Systemic lupus erythematosus: One year in review 2023. Clin. Exp. Rheumatol. 41(5), 997\u20131008 (2023).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"17","key":"95467_CR2","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel, C. H. & Sammaritano, L. R. Systemic lupus erythematosus: A review. JAMA 331(17), 1480\u20131491 (2024).","journal-title":"JAMA"},{"issue":"2","key":"95467_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.berh.2018.09.004","volume":"32","author":"I Gergianaki","year":"2018","unstructured":"Gergianaki, I., Bortoluzzi, A. & Bertsias, G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract. Res. Clin. Rheumatol. 32(2), 188\u2013205 (2018).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"2","key":"95467_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/acr.24431","volume":"74","author":"Y Tanaka","year":"2022","unstructured":"Tanaka, Y. et al. Systemic lupus erythematosus: Targeted literature review of the epidemiology, current treatment, and disease burden in the Asia Pacific Region. Arthritis Care Res. (Hoboken) 74(2), 187\u2013198 (2022).","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"9","key":"95467_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber, M. R. W. et al. Global epidemiology of systemic lupus erythematosus. Nat. Rev. Rheumatol. 17(9), 515\u2013532 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"95467_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.semarthrit.2017.10.001","volume":"47","author":"G Gulati","year":"2018","unstructured":"Gulati, G. & Brunner, H. I. Environmental triggers in systemic lupus erythematosus. Semin Arthritis Rheum 47(5), 710\u2013717 (2018).","journal-title":"Semin Arthritis Rheum"},{"key":"95467_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imlet.2021.06.004","volume":"237","author":"A Rasouli-Saravani","year":"2021","unstructured":"Rasouli-Saravani, A. et al. Relevance of autoantibody profile with HLA-DRB1 and -DQB1 alleles in a group of Iranian systemic lupus erythematosus patients. Immunol. Lett. 237, 11\u201316 (2021).","journal-title":"Immunol. Lett."},{"key":"95467_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3389\/fimmu.2018.00875","volume":"9","author":"E Weeding","year":"2018","unstructured":"Weeding, E. & Sawalha, A. H. Deoxyribonucleic acid methylation in systemic lupus erythematosus: Implications for future clinical practice. Front. Immunol. 9, 875 (2018).","journal-title":"Front. Immunol."},{"key":"95467_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.964263","volume":"13","author":"M Northcott","year":"2022","unstructured":"Northcott, M. et al. Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus. Front. Immunol. 13, 964263 (2022).","journal-title":"Front. Immunol."},{"issue":"6","key":"95467_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","volume":"21","author":"GC Tsokos","year":"2020","unstructured":"Tsokos, G. C. Autoimmunity and organ damage in systemic lupus erythematosus. Nat. Immunol. 21(6), 605\u2013614 (2020).","journal-title":"Nat. Immunol."},{"issue":"10","key":"95467_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.526","volume":"11","author":"K Kaneko","year":"2021","unstructured":"Kaneko, K. et al. Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients. Clin. Transl. Med. 11(10), e526 (2021).","journal-title":"Clin. Transl. Med."},{"issue":"2 Pt 2","key":"95467_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.reuma.2018.05.002","volume":"16","author":"J Mendoza-Alonzo","year":"2020","unstructured":"Mendoza-Alonzo, J., Zayas-Castro, J. & Soto-Sandoval, K. Osteonecrosis in individuals with systemic lupus erythematosus: A predictive model. Reumatol. Clin. (Engl. Ed.) 16(2 Pt 2), 161\u2013164 (2020).","journal-title":"Reumatol. Clin. (Engl. Ed.)"},{"issue":"5","key":"95467_CR13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/os.12788","volume":"12","author":"P Hernigou","year":"2020","unstructured":"Hernigou, P., Hernigou, J. & Scarlat, M. Shoulder osteonecrosis: Pathogenesis, causes, clinical evaluation, imaging, and classification. Orthop. Surg. 12(5), 1340\u20131349 (2020).","journal-title":"Orthop. Surg."},{"issue":"9","key":"95467_CR14","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/annrheumdis-2022-222345","volume":"81","author":"X Yin","year":"2022","unstructured":"Yin, X. et al. Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study. Ann. Rheum. Dis. 81(9), 1273\u20131280 (2022).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"95467_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2020.20013","volume":"8","author":"V Torrente-Segarra","year":"2021","unstructured":"Torrente-Segarra, V. & Bonet, M. Multifocal osteonecrosis in systemic lupus erythematosus: Two case reports and literature review. Eur. J. Rheumatol. 8(1), 46\u201347 (2021).","journal-title":"Eur. J. Rheumatol."},{"issue":"10","key":"95467_CR16","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3899\/jrheum.170837","volume":"45","author":"S Hussein","year":"2018","unstructured":"Hussein, S. et al. Monitoring of osteonecrosis in systemic lupus erythematosus: A systematic review and metaanalysis. J. Rheumatol. 45(10), 1462\u20131476 (2018).","journal-title":"J. Rheumatol."},{"key":"95467_CR17","doi-asserted-by":"publisher","first-page":"1381035","DOI":"10.3389\/fimmu.2024.1381035","volume":"15","author":"W Xu","year":"2024","unstructured":"Xu, W. et al. Risk factors and prediction model for osteonecrosis of the femoral head in female systemic lupus erythematosus. Front. Immunol. 15, 1381035 (2024).","journal-title":"Front. Immunol."},{"issue":"4","key":"95467_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden, J. & Holmes, M. V. Meta-analysis and Mendelian randomization: A review. Res. Synth. Methods 10(4), 486\u2013496 (2019).","journal-title":"Res. Synth. Methods"},{"key":"95467_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.110986","volume":"132","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Genome-wide association studies (GWAS) and post-GWAS analyses of impulsivity: A systematic review. Prog. Neuropsychopharmacol. Biol. Psychiatry 132, 110986 (2024).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7886","key":"95467_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599(7886), 628\u2013634 (2021).","journal-title":"Nature"},{"issue":"5","key":"95467_CR21","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/ije\/dyw088","volume":"45","author":"DI Swerdlow","year":"2016","unstructured":"Swerdlow, D. I. et al. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int. J. Epidemiol. 45(5), 1600\u20131616 (2016).","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"95467_CR22","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska, O. O. & Burgess, S. MendelianRandomization: An R package for performing Mendelian randomization analyses using summarized data. Int. J. Epidemiol. 46(6), 1734\u20131739 (2017).","journal-title":"Int. J. Epidemiol."},{"issue":"7","key":"95467_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37(7), 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"issue":"2","key":"95467_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44(2), 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"95467_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J. et al. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40(4), 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"issue":"9","key":"95467_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222362","volume":"14","author":"JMB Rees","year":"2019","unstructured":"Rees, J. M. B. et al. Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates. PLoS ONE 14(9), e0222362 (2019).","journal-title":"PLoS ONE"},{"issue":"1","key":"95467_CR27","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe, K. et al. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8(1), 1826 (2017).","journal-title":"Nat. Commun."},{"issue":"4","key":"95467_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw, C. A. et al. MAGMA: Generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11(4), e1004219 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"95467_CR29","doi-asserted-by":"crossref","unstructured":"Noordam, R. Mendelian randomization-let\u2019s prevent common mistakes. J. Gerontol. A Biol. Sci. Med. Sci. 79(11) (2024).","DOI":"10.1093\/gerona\/glae199"},{"key":"95467_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070856","volume":"384","author":"P Brown","year":"2024","unstructured":"Brown, P., Pratt, A. G. & Hyrich, K. L. Therapeutic advances in rheumatoid arthritis. BMJ 384, e070856 (2024).","journal-title":"BMJ"},{"issue":"4","key":"95467_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3899\/jrheum.2023-0334","volume":"51","author":"LJ O'Neil","year":"2024","unstructured":"O\u2019Neil, L. J., Alp\u00edzar-Rodr\u00edguez, D. & Deane, K. D. Rheumatoid arthritis: The continuum of disease and strategies for prediction, early intervention, and prevention. J. Rheumatol. 51(4), 337\u2013349 (2024).","journal-title":"J. Rheumatol."},{"issue":"4","key":"95467_CR32","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.jds.2024.07.024","volume":"19","author":"K Seki","year":"2024","unstructured":"Seki, K. et al. Medication-related osteonecrosis of the jaw in a patient with rheumatoid arthritis with suspected involvement of methotrexate and tocilizumab. J. Dent. Sci. 19(4), 2428\u20132429 (2024).","journal-title":"J. Dent. Sci."},{"issue":"1","key":"95467_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0961203317711012","volume":"27","author":"DD Gladman","year":"2018","unstructured":"Gladman, D. D. et al. Osteonecrosis in SLE: Prevalence, patterns, outcomes and predictors. Lupus 27(1), 76\u201381 (2018).","journal-title":"Lupus"},{"issue":"7","key":"95467_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046163","volume":"11","author":"Q Wei","year":"2021","unstructured":"Wei, Q. et al. Relationship between osteonecrosis and antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review protocol. BMJ Open 11(7), e046163 (2021).","journal-title":"BMJ Open"},{"issue":"10","key":"95467_CR35","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1177\/09612033211031007","volume":"30","author":"M Ersin","year":"2021","unstructured":"Ersin, M. et al. Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course. Lupus 30(10), 1603\u20131608 (2021).","journal-title":"Lupus"},{"issue":"8","key":"95467_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/rheumatology\/keu148","volume":"53","author":"I Ruiz-Arruza","year":"2014","unstructured":"Ruiz-Arruza, I. et al. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 53(8), 1470\u20131476 (2014).","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"95467_CR37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.60.12.1145","volume":"60","author":"K Oinuma","year":"2001","unstructured":"Oinuma, K. et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann. Rheum. Dis. 60(12), 1145\u20131148 (2001).","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"95467_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00296-016-3502-7","volume":"36","author":"L Zhao","year":"2016","unstructured":"Zhao, L. et al. Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: A case-control study. Rheumatol. Int. 36(8), 1105\u20131111 (2016).","journal-title":"Rheumatol. Int."},{"issue":"1","key":"95467_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10067-017-3820-5","volume":"37","author":"K Zhang","year":"2018","unstructured":"Zhang, K. et al. Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: A systematic review and meta-analysis. Clin. Rheumatol. 37(1), 5\u201311 (2018).","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"95467_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.25122\/jml-2023-0314","volume":"17","author":"R Desai","year":"2024","unstructured":"Desai, R. et al. SLE and multiple myeloma: An underlooked link? A review of case reports from the last decade. J. Med. Life 17(2), 141\u2013146 (2024).","journal-title":"J. Med. Life"},{"issue":"1","key":"95467_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan, L. et al. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J. Pediatr. 16(1), 19\u201330 (2020).","journal-title":"World J. Pediatr."},{"issue":"12","key":"95467_CR42","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47(12), 1457\u20131464 (2015).","journal-title":"Nat. Genet."},{"issue":"4","key":"95467_CR43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/09273948.2020.1828937","volume":"30","author":"S Kuthyar","year":"2022","unstructured":"Kuthyar, S. et al. Systemic lupus erythematosus-associated retinal vasculitis treated with adalimumab. Ocul. Immunol. Inflamm. 30(4), 981\u2013985 (2022).","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"8","key":"95467_CR44","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/1744666X.2021.1925109","volume":"17","author":"W Qijiao","year":"2021","unstructured":"Qijiao, W. et al. Antiphospholipid antibodies and osteonecrosis in systemic lupus erythematosus: A meta-analysis. Expert Rev. Clin. Immunol. 17(8), 923\u2013932 (2021).","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"7","key":"95467_CR45","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/acr.24541","volume":"74","author":"R Kallas","year":"2022","unstructured":"Kallas, R., Li, J. & Petri, M. Predictors of osteonecrosis in systemic lupus erythematosus: A prospective cohort study. Arthritis Care Res. (Hoboken) 74(7), 1122\u20131132 (2022).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"95467_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2018.05.020","volume":"103","author":"CA K\u00f6hler","year":"2018","unstructured":"K\u00f6hler, C. A. et al. Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies. J. Psychiatr. Res. 103, 189\u2013207 (2018).","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"95467_CR47","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00296-011-1815-0","volume":"32","author":"M Abeles","year":"2012","unstructured":"Abeles, M. et al. Osteonecrosis in SLE. Rheumatol. Int. 32(3), 833 (2012).","journal-title":"Rheumatol. Int."},{"issue":"9","key":"95467_CR48","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1093\/rheumatology\/kead016","volume":"62","author":"D Webber","year":"2023","unstructured":"Webber, D. et al. Genetics of osteonecrosis in children and adults with systemic lupus erythematosus. Rheumatology (Oxford) 62(9), 3205\u20133212 (2023).","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"95467_CR49","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/ker410","volume":"51","author":"G Ruiz-Irastorza","year":"2012","unstructured":"Ruiz-Irastorza, G., Danza, A. & Khamashta, M. Glucocorticoid use and abuse in SLE. Rheumatology (Oxford) 51(7), 1145\u20131153 (2012).","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"95467_CR50","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00296-009-0956-x","volume":"30","author":"M Salesi","year":"2010","unstructured":"Salesi, M. et al. A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur. Rheumatol. Int. 30(4), 527\u2013529 (2010).","journal-title":"Rheumatol. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95467-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95467-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95467-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:04:19Z","timestamp":1745924659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95467-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95467"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95467-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study does not involve animal or human trials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal ethics"}}],"article-number":"15040"}}